Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.

Diop OM, Burns CC, Sutter RW, Wassilak SG, Kew OM.

MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):640-6.

2.

Epidemiology and genetic characterization of measles strains in Senegal, 2004-2013.

Dia N, Fall A, Ka R, Fall A, Kiori DE, Goudiaby DG, Fall AD, Faye el HA, Dosseh A, Ndiaye K, Diop OM, Niang MN.

PLoS One. 2015 May 22;10(5):e0121704. doi: 10.1371/journal.pone.0121704. eCollection 2015.

3.

Progress toward polio eradication - worldwide, 2014-2015.

Hagan JE, Wassilak SG, Craig AS, Tangermann RH, Diop OM, Burns CC, Quddus A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 May 22;64(19):527-31.

4.

Tracking progress toward polio eradication - worldwide, 2013-2014.

Porter KA, Diop OM, Burns CC, Tangermann RH, Wassilak SG.

MMWR Morb Mortal Wkly Rep. 2015 Apr 24;64(15):415-20.

5.

Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?

Michel R, Berger F, Ravelonarivo J, Dussart P, Dia M, Nacher M, Rogier S, Moua D, Sarr FD, Diop OM, Sall AA, Baril L.

Vaccine. 2015 May 11;33(20):2301-6. doi: 10.1016/j.vaccine.2015.03.069. Epub 2015 Apr 2.

PMID:
25843268
6.

Possible eradication of wild poliovirus type 3--worldwide, 2012.

Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, Tangermann RH, Armstrong GL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1031-3.

7.

Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S5-15. doi: 10.1093/infdis/jiu456. Review.

PMID:
25316873
8.

Environmental surveillance for polioviruses in the Global Polio Eradication Initiative.

Asghar H, Diop OM, Weldegebriel G, Malik F, Shetty S, El Bassioni L, Akande AO, Al Maamoun E, Zaidi S, Adeniji AJ, Burns CC, Deshpande J, Oberste MS, Lowther SA.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S294-303. doi: 10.1093/infdis/jiu384. Review.

PMID:
25316848
9.

Vaccine-derived polioviruses.

Burns CC, Diop OM, Sutter RW, Kew OM.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S283-93. doi: 10.1093/infdis/jiu295. Review.

PMID:
25316847
10.

Progress toward polio eradication--Worldwide, 2013-2014.

Moturi EK, Porter KA, Wassilak SG, Tangermann RH, Diop OM, Burns CC, Jafari H; EIS officer, CDC.

MMWR Morb Mortal Wkly Rep. 2014 May 30;63(21):468-72.

11.

Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013.

Levitt A, Diop OM, Tangermann RH, Paladin F, Kamgang JB, Burns CC, Chenoweth PJ, Goel A, Wassilak SG; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):356-61.

12.

Respiratory viruses associated with patients older than 50 years presenting with ILI in Senegal, 2009 to 2011.

Dia N, Richard V, Kiori D, Cisse el HA, Sarr FD, Faye A, Goudiaby DG, Diop OM, Niang MN.

BMC Infect Dis. 2014 Apr 8;14:189. doi: 10.1186/1471-2334-14-189.

13.

Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.

Diop OM, Burns CC, Wassilak SG, Kew OM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):242-8.

14.

Multiyear persistence of 2 pandemic A/H1N1 influenza virus lineages in West Africa.

Nelson MI, Njouom R, Viboud C, Niang MN, Kadjo H, Ampofo W, Adebayo A, Tarnagda Z, Miller MA, Holmes EC, Diop OM.

J Infect Dis. 2014 Jul 1;210(1):121-5. Epub 2014 Jan 19.

15.

Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013).

Ndiaye AK, Diop PA, Diop OM.

Pan Afr Med J. 2014 Nov 4;19:243. doi: 10.11604/pamj.2014.19.243.3538. eCollection 2014.

16.

A subregional analysis of epidemiologic and genetic characteristics of influenza A(H1N1)pdm09 in Africa: Senegal, Cape Verde, Mauritania, and Guinea, 2009-2010.

Dia N, Ndiaye MN, Monteiro Mde L, Koivogui L, Bara MO, Diop OM.

Am J Trop Med Hyg. 2013 May;88(5):946-53. doi: 10.4269/ajtmh.12-0401. Epub 2013 Mar 18.

17.

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Duintjer Tebbens RJ, Pallansch MA, Kim JH, Burns CC, Kew OM, Oberste MS, Diop OM, Wassilak SG, Cochi SL, Thompson KM.

Risk Anal. 2013 Apr;33(4):680-702. doi: 10.1111/risa.12022. Epub 2013 Mar 7.

PMID:
23470192
18.

Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.

Dia N, Niang MN, Diadhiou SA, Goudiaby DG, Faye A, Kiori D, Bâ M, Michel R, Diop OM.

BMC Infect Dis. 2013 Feb 27;13:106. doi: 10.1186/1471-2334-13-106.

19.

Spatiotemporal circulation of influenza viruses in 5 African countries during 2008-2009: a collaborative study of the Institut Pasteur International Network.

Heraud JM, Njouom R, Rousset D, Kadjo H, Caro V, Ndiaye MN, Victoir K, Collard JM, Orelle A, Yekwa EL, Ekaza E, Razanajatovo NH, Adamou L, Biscornet L, Enouf V, van der Werf S, Diop OM.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S5-13. doi: 10.1093/infdis/jis541.

20.

Sentinel surveillance for influenza in Senegal, 1996-2009.

Niang MN, Dosseh A, Ndiaye K, Sagna M, Gregory V, Goudiaby D, Hay A, Diop OM.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S129-35. doi: 10.1093/infdis/jis576.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk